Espi-Bastien, D., Raimbourg, J., Bougras-Cartron, G., Nadaradjane, A., Blondeau, S., Dupas, G., Volard, B., Lefrançois, A., Gautier, F., Mazières, J., Morin, F., Molinier, O., Barlesi, F., Amour, E., Dupé, M., Cartron, P. (2026). Circulating epigenetic and epitranscriptomic biomarkers identify EGFR status, predict TKI response and reveal therapeutic vulnerabilities in NSCLC. Scientific Reports. https://doi.org/10.1038/s41598-026-62035-y